NIKKEI 225
38,347.30 +144.93 (+0.38%) HANG SENG
18,422.23 +108.37 (+0.59%) CRUDE OIL
79.31 +0.32 (+0.41%) GOLD FUTURES
2,315.90 -6.40 (-0.28%) DOW
39,056.39 +172.13 (+0.44%) Bitcoin GBP
49,236.82 -983.42 (-1.96%)
Sana Biotechnology, Inc. (SANA)
After hours:
| Previous close | 10.04 |
| Open | 9.67 |
| Bid | 9.44 x 100 |
| Ask | 9.53 x 100 |
| Day's range | 9.23 - 9.90 |
| 52-week range | 2.74 - 12.00 |
| Volume | |
| Avg. volume | 1,964,785 |
| Market cap | 2.1B |
| Beta (5Y monthly) | 1.61 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.46 |
| Earnings date | 01 Aug 2024 - 05 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 12.40 |
GlobeNewswireSana Biotechnology Reports First Quarter 2024 Financial Results and Business Updates
Goal to treat 40-60 patients in 2024 in four trials across seven indications in oncology, B-cell mediated autoimmune diseases, and type 1 diabetes Ongoing ARDENT trial for SC291 continues in B-cell malignancies; expect to report additional data in 2024 Enrolling patients in the ongoing GLEAM trial for SC291 in B-cell mediated autoimmune diseases; expect to report initial clinical data in 2024 Enrolling patients in the ongoing VIVID trial for SC262 in relapsed/refractory B-cell malignancies; expe
- GlobeNewswire
Sana Biotechnology to Present at May and June 2024 Investor Conferences
SEATTLE, May 06, 2024 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webcast its presentations at three investor conferences in May and June. The presentations will feature a business overview and update. Sana will present at the Citizens JMP Securities Life Sciences Conference at 11:30 a.m. ET on Monday, May 13, 2024.Sana will present at the BofA Securities 2024 Healthcar
Zacks4 Stocks to Keep a Tab on for Amazing Earnings Acceleration
Notable companies to have witnessed solid earnings acceleration as of now are Sana Biotechnology (SANA), LifeMD (LFMD), Evolus (EOLS) and Expro Group Holdings (XPRO).
